Related Experiment Video

Updated: Dec 21, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.9K

2019-nCoV - Towards a 4th generation vaccine.

Francesco Chiappelli1

  • 1UCLA Center for the Health Sciences, Los Angeles, CA, USA, Francesco.

Bioinformation
|May 15, 2020
PubMed
Summary

A novel coronavirus (2019-nCoV) caused pneumonia, spreading globally with no current vaccine or treatment. This paper proposes a hypothetical clinical protocol for prevention and treatment of COVID-19.

Keywords:
Angiotensin-converting enzyme-2 (ACE2)Middle-East Respiratory Syndrome (MERS)Novel Coronavirus (emerged late) 2019 (2019-nCoV Corona Virus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome (SARS)transcription regulatory networks (TRNs) Corona virus (CoV)

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.7K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
50.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
869
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
664